Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Launches two models of its Jewel biphasic implantable defibrillators with Active Can technology in international markets. Model 7219C, which provides cardioversion, defibrillation, and tachyarrhythmia pacing, is released in Canada, the European Community, and Latin America; Model 7202C, with cardioversion and defibrillation capability, enters the EC and Latin American markets. The Active Can feature allows the Jewel system to be implanted pectorally with a single Transvene transvenous lead because the device case serves as an electrode ("The Gray Sheet" Sept. 27, 1993, I&W-6). Both devices are in clinicals in the U.S
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel